Branch TIBS 23:45-50 (Feb. 1998).* |
Gewirtz et al. PNAS 93: 3161-3163 (1996).* |
Rojauasakul et al. Adv. Drug Delresy Bev 18:115-131, 1996.* |
Choo et al., “Genetic organization and diversity of hepatitis C virus,” Proc. Natl. Acad. Sci. 1991, 88, 2451-2455. |
Choo et al., “Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome,” Science 1989, 244, 359-362. |
Han et al., “Characterization of the terminal regions of hepatitis C viral RNA: Indentification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end,” Proc. Natl. Acad. Sci. 1991, 88, 1711-1715. |
Inchauspe et al., “Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates,” Proc. Natl. Acad. Sci. 1991, 88, 10292-10296. |
Inoue, et al., “Synthesis and hybridization studies on two complementary nona (2′-O-methyl) ribonucleotides,” Nucleic Acids Research 1991, 15:6131-6148. |
Nielsen et al., “Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide,” Science 1991, 254:1497-1500. |
Rothenberg et al., “Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications,” J. Natl. Cancer Inst. 1989, 81:1539-1544. |
Sproat et al., “New synthetic routes to protected purine 2′-O-methylriboside-3′-O-phosphoramidites using a novel alkylation procedure,” Nucleic Acids Research 18:41-49 (1990). |
Takamizawa et al., “Structure and organization of the hepatitis C virus genome isolated from human carriers,” J. Virol. 1991, 65:1105-1113. |
Tsukiyama-Kohara et al., “Internal ribosome entry site within hepatitis C virus RNA,” J. Virol. 1992, 66:1476-1483. |
Zon, G., “Oligonucleotide analogues as potential chemotherapeutic agents,” Pharmaceutical Res. 1987, 5:539-549. |